AVE 0.00% 0.2¢ avecho biotechnology limited

mastitis-the holy grail?, page-14

  1. 5,322 Posts.
    Yilgarn - According to MMA- It is still conducting followup tests and applying the product and the dosage information has continued to show outstanding results. But the next step seems to be commercial rollout in September 2011 for Australia and the granting of Global Licence to a company like Novartis or Eli Lilly Animal Health for international sales
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.